Do quality incentives change prescribing patterns in primary care? An observational study in Scotland

Family Practice

Volumn 25, Issue 1, 2008, Pages 27-32

  MacBride Stewart, Sean P ^a   Elton, Rob ^b   Walley, Tom ^c  

^a NHS LOTHIAN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Defined daily dose; Drug utilization; General Medical Services; Prescribing; Quality and Outcomes Framework

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTRACT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG FORMULARY; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HUMAN; ISCHEMIC HEART DISEASE; OBSERVATIONAL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; TIME SERIES ANALYSIS; UNITED KINGDOM;

CONTRACTS; HUMANS; NATIONAL HEALTH PROGRAMS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; SCOTLAND;

EID: 41149154477     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmm074     Document Type: Article

References (21)

1. Ahmed P, Cadenhead L. Charting the developments in the NHS. Health Manpow Manage 1998; 24: 222-228.
2. Harris C, Scrivener G. Fundholders' prescribing costs: The first five years. BMJ 1996; 313: 1531-1534.
3. Maxwell M, Heaney D, Howie JGR, Noble S. General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method. BMJ 1993; 307: 1190-1194.
4. Wilson R, Buchan I, Walley T. Alterations in prescribing by general practitioner fundholders: An observational study. BMJ 1995; 31 1347-1350.
5. Marek K, Rodnick J. Recent developments in primary care in the United Kingdom: From competition to community-oriented primary care. J Fam Pract 1999; 48: 140-145.
6. Ashworth M, Lea R, Gray H, Rowlands G, Gravelle H, Majeed A. How are primary care organization using financial incentives to influence prescribing? J Public Health 2004; 26: 48-51.
7. Roland M. Linking physicians pay to quality of care - a major experiment in the UK. N Engl J Med 2004; 351: 1448-1454.
8. McElduff P, Lyratzopoulos G, Edwards R, Heller RF, Shekelle P, Roland M. Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK. Qual Saf Health Care 2004; 13 (3): 191-197.
9. NHS Lothian. Director of Public Health Annual Report. http://www.nhslothian.scot.nhs.uk/news/annual_reports/publichealth/2005/ index.htm (accessed on January 30, 2007).
10. The WHO Collaborating Centre for Drug Statistics Methodology. The ATC/ DDD System. http://www.whocc.no/atcddd/ (accessed on January 30, 2007).
11. Prescription Pricing Authority. Prescribing Measures and Their Application. http://www.ppa.org.uk/help/toolkit/pre_meas.htm (accessed on January 30, 2007).
12. BNF 50. British National Formulary. 50th edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2005.
13. England E. How interrupted time series analysis can evaluate guideline implementation. Pharm J 2005; 275: 344-347.
14. Campbell SM, Roland MO, Middleton E, Reeves D. Improvement in quality of clinical care in English general practice 1998-2003: Longitudinal observational study. BMJ 2005; 331: 1121-1125.
15. Doran T, Fullwood C, Gravelle H et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 2006; 355: 375-384.
16. Campbell S, Reeves D, Kontopantelis E, Middleton E, Sibbald B, Roland M. Quality of primary care in England with the introduction of pay for performance. N Engl J Med 2007; 357: 181-190.
17. McCarlie J, Reid E, Brady AJB. Audit of the new GMS contract quality and outcomes framework: Raising standards in CHD. Br J Cardiol 2007; 14: 117-119.
18. National Audit Office. Prescribing Costs in Primary Care. London: The Stationery Office, 2007.
19. Scottish Health, Statistics Website of ISD. Quality and Outcomes Framework, http://www.isdscotland.org/isd/3305.html (accessed on January 30, 2007).
20. Walley T, Folino-Gallo, P, Stephens P, Van Ganse E. Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003. Br J Clin Pharmacol 2005; 60: 543-551.
21. Pirmohamed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 2004; 329: 15-19.